Biomonitoring of workers exposed to lead. Genotoxic effects, its modulation by polyvitamin treatment and evaluation of the induced radioresistance

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 418, Issue 2-3, 1998, Pages 79-92

  Vaglenov, A ^a   Carbonell, E ^b   Marcos, R ^b  

^a National Center of Radiobiology and Radiation Protection Bulgaria   (Bulgaria)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Lead; Polymineral; Polyvitamin

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM; ANTIMUTAGENIC AGENT; ASCORBIC ACID; LEAD; MINERAL; MULTIVITAMIN; SELENIUM; ZINC;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTOXICITY; HUMAN; LEAD BLOOD LEVEL; MALE; OCCUPATIONAL EXPOSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOSENSITIVITY;

ADULT; ALCOHOL DRINKING; BULGARIA; ENVIRONMENTAL MONITORING; HUMANS; LEAD; LEAD POISONING; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; QUESTIONNAIRES; SMOKING; VITAMINS;

EID: 0031719640     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00111-9     Document Type: Article

References (60)

1. Pirkle J.L., Brody D.J., Gunter E.W., Kramer R.A., Paschal D.C., Flegal K.M., Matte T.D. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA. 272:1994;284-291.
2. Todd A.C., Wetmur J.G., Moline J.M., Godbold J.H., Levin S.M., Landrigan P.J. Unravelling the chronic toxicity of lead: an essential priority for environmental health. Environ. Health. Perspec. 104:1996;141-146.
3. Gerber G.B., Léonard A., Jacquet P. Toxicity, mutagenicity and teratogenicity of lead. Mutation Res. 76:1980;115-141.
4. Goyer R.A. Lead toxicity: current concerns. Environ. Health. Perspec. 100:1993;177-187.
5. Dunkel V.C., Zeiger E., Brusick D., McCoy E., McGregor D., Mortelmans K., Rosenkrantz H.S., Simmon V.F. Reproducibility of microbial mutagenicity assays: I. tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ. Mol. Mutagen. 6:1984;1-254.
6. Zelikoff J.T., Li J.H., Ahartwig A., Wang X.W., Costa M., Rossman T.G. Genetic toxicology of lead compounds. Carcinogenesis. 9:1988;1727-1732.
7. Winder C., Bonin T. The genotoxicity of lead. Mutation Res. 285:1993;117-124.
8. Johansson L., Pellicciari C.E. Lead induced changes in the stabilization of the mouse sperm chromatin. Toxicology. 51:1988;11-24.
9. Hartwig A., Schlepegrell R., Beyersmann D. Indirect mechanism of lead induced genotoxicity in cultured mammalian cells. Mutation Res. 241:1990;75-82.
10. International Agency for Research on Cancer, Overall evaluation of carcinogenic and updating of IARC Monographs, Vol. 1 to 42, IARC Monogr. Eval. Carcinog. Risks Hum., 1987, 1-42.
11. Fu H., Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup. Environ. Med. 52:1995;73-81.
12. Hayatsu H., Arimoto S., Negeshi T. Dietary inhibitors of mutagenesis and carcinogenesis. Mutation Res. 202:1988;429-446.
13. 12 and folic acid. Carcinogenesis. 15:1994;1405-1411.
14. Byers T., Perry G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu. Rev. Nutr. 12:1992;139-159.
15. Lazutka J.R. Chromosome aberrations and rogue cells in lymphocytes of Chernobyl clean-up workers. Mutation Res. 350:1996;315-329.
16. Emerit I., Oganesian N., Arutyunian R., Pogossian A., Sarkisian T., Cernjavski L., Levy A., Feingold J. Oxidative stress-related clastogenic factors in plasma from Chernobyl liquidators: protective effects of antioxidant plant phenols, vitamins and oligoelements. Mutation Res. 377:1997;239-246.
17. Oganesian N., Emerit I., Pogosian A., Abramiam A., Arutyunian R., Agrian K., Sarkisian T., Esyan A. Antioxidant treatment of radiation injuries. Antioxid. Radiat. Injuries. 3:1997;125-131.
18. Wolff S., Jostes R., Cross F.T., Hui T.E., Afzaal V., Wiencke J.K. Adaptive response of human lymphocytes for repair of radon induced chromosome damage. Mutation Res. 250:1991;299-306.
19. Tedeschi B., Caporossi D., Vernole P., Padovani L., Appolloni M., Anzidei P., Mauro F. Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? 2. Challenge with bleomycin. Mutation Res. 332:1995;39-44.
20. Mayer J., Warburton D., Jeffery A.M., Pero R., Walles S., Andrews L., Toor M., Latriano L., Wazneh L., Tang D., Tsai W.Y., Kuroda M., Perera F. Biologic markers in ethylene oxide-exposed workers and controls. Mutation Res. 248:1991;163-176.
21. Au W.W., Bechtold W.E., Whorton Jr E.B., Legator M.S. Chromosome aberrations and response to γ-ray challenge in lymphocytes of workers exposed to 1,3-butadiene. Mutation Res. 334:1995;125-130.
22. Padovani L., Apolloni M., Anzidei P., Tedeschi B., Caporosi D., Vernole P., Mauro F. Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit adaptive response? 1. Challenge with ionizing radiation. Mutation Res. 332:1995;33-38.
23. Wojcik A., Sauer K., Zölzer F., Bauch T., Müller W.-U. Analysis of DNA damage recovery processes in the adaptive response to ionizing radiation in human lymphocytes. Mutagenesis. 11:1996;291-297.
24. Carrano A.V., Natarajan A.T. Consideration for population monitoring using cytogenetic techniques. Mutation Res. 204:1988;370-406.
25. Fenech M. Cytokinesis-block micronucleus techniques: a detailed description of the method and its application to genotoxicity studies in human populations. Mutation Res. 161:1993;193-198.
26. Surrallés J., Antoccia A., Creus A., Degrassi F., Peris F., Tanzarella C., Xamena N., Marcos R. The effect of cytochalasin-B concentration on the frequency of micronuclei induced by four standard mutagens. Results from two laboratories. Mutagenesis. 9:1994;347-353.
27. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutation Res. 147:1985;29-36.
28. M. Bauchinger, H. Braselmann, Use of the micronuclei in biological dosimetry of absorbed radiation dose, in: G. Obe, A.T. Natarajan (Eds.), Chromosomal Aberration, Basic and Applied Aspects, Springer-Verlag, Berlin, 1990, pp. 202-211.
29. Lee T.-K., Wiley A.L. Jr., Esinhart J.D., Blanckburn L.D. Radiation dose-dependent variations of micronuclei production in cytochalasin B-blocked human lymphocytes. Teratogen. Carcinogen. Mutagen. 14:1994;1-12.
30. Kanematsu N., Hara M., Kada T. Rec assay and mutagenicity studies on metal compounds. Mutation Res. 77:1980;109-116.
31. s (λ). Environ. Mutagen. 6:1984;59-69.
32. De Knudt G.H., Colli A., Gerber G.B. Chromosomal abnormalities in lymphocytes from monkeys poised with lead. Mutation Res. 45:1977;77-83.
33. Forni A., Cambiaghi G., Secchi G.C. Initial exposure to lead: chromosome and biochemical findings. Arch. Environ. Health. 31:1976;73-78.
34. Nordenson I., Beckman G., Beckman L., Northstrom S. Occupational and environmental risks in and around a smelter in Northern Sweden: IV. Chromosomal aberrations in workers exposed to lead. Hereditas. 88:1978;263-267.
35. Forni A. Chromosomal effects of lead: a critical review. Rev. Environ. Health. 3:1980;114-129.
36. Vaglenov A.K., Laltchev S.G., Nosko M.S., Pavlova S.P., Petkova V.V., Karadjov A.D. Cytogenetic monitoring of exposed workers to lead. Central Eur. J. Occup. Environ. Med. 3:1997;298-308.
37. EPA Evaluation of the potential carcinogenicity of lead and lead compounds, Washington: US Environmental Protection agency, Office of Health and Environmental Assessment, 1989, (EPA/600/8-89/045A).
38. Kentner M., Fischer T., Richter G. Changes in external and internal lead load in different working areas of a starter battery production plant in the period 1982 to 1991. Int. Arch. Occup. Environ. Health. 66:1994;23-31.
39. Roy N.K., Rossman T.G. Mutagenesis and comutagenesis by lead compounds. Mutation Res. 298:1992;97-103.
40. 2 formation by human polymorphonuclear leukocytes. Cancer Res. 50:1990;7564-7570.
41. Popenoe E.A., Schmaelet M.A. Interaction of human DNA polymerase β with ions of copper, lead and cadmium. Arch. Biochem. Biophys. 106:1979;109-120.
42. A. Léonard, G.B. Gerber, P. Jacquet, R. Lauweys, Carcinogenicity, mutagenicity and teratogenicity of industrial used metals, in: M. Kirsch-Volders (Ed.), Mutagenicity, Carcinogenicity and Teratogenicity of Industrial Pollutants, Plenum, New York, 1984, pp. 59-126.
43. Sram R., Dobias L., Pastorkova A., Rossner P., Ianca L. Effects of ascorbic acid prophylaxis on the frequency of chromosome aberrations in the peripheral lymphocytes of coal-tar workers. Mutation Res. 120:1983;181-186.
44. Mierauskiene J., Lekevicius R., Latzutka J.R. Anticlastogenic effects of Aevitum intake in a group of chemical industry workers. Hereditas. 118:1993;201-204.
45. Vaglenov A.K., Yaneva E.G., Laltchev S.G., Nosko M.S., Petkova V.P., Pavlova S.D., Doneva K.V., Demirova M.I., Kehajov D.A. Antimutagenic prophylaxis of occupational risk groups. Central Eur. J. Occup. Environ. Med. 3:1997;114-124.
46. P. van't Veer, E. Guallar, F.J. Kok, J.M. Martin-Moreno, Vitamins, oligo-elements and cancer prevention: epidemiological evidence, in: C. Maltoni, M. Soffritti, W. Davis (Eds.), The Scientific Bases of Cancer Chemoprevention, Elsevier, 1996, pp. 137-145.
47. van Poppel G., van den Berg H. Vitamins and cancer. Cancer Lett. 114:1997;195-202.
48. Sweetman S.F., Strain J.J., McKelvey-Martin V.J. Effect of antioxidant vitamins supplementation on DNA damage and repair in human lymphoblastoid cells. Nutr. Cancer. 27:1997;122-130.
49. Umegaki K., Ikegami S., Inoue K., Ichikaua T., Soeno M., Tomabechi K. Beta-carotene prevents X-ray induction of micronuclei in human lymphocytes. Am. J. Clin. Nutr. 59:1994;409-412.
50. Kasprzak K.S. Possible role of oxidative damage in metal induced carcinogenesis. Environ. Carcinogen. 13:1995;411-430.
51. Susa N., Ueno S., Furukawa Y., Sugiyama M. Protective effect of vitamin E on chromium (VI)-induced cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes. Arch. Toxicol. 71:1996;20-24.
52. Dhir H., Roy A.K., Sharma A. Relative efficience of Phyllanthus emblica fruit extract and ascorbic acid in modifying lead and aluminium-induced sister-chromatid exchanges in mouse bone marrow. Environ. Mol. Mutagen. 21:1993;229-236.
53. Au W.W., Walker D.M., Ward J.B. Jr., Whorton E.B. Jr., Legator M.S., Singh V. Factors contributing to chromosome damage in lymphocytes of cigarette smokers. Mutation Res. 260:1991;137-144.
54. Au W.W., Bechtold W.E., Whorton E.B. Jr., Legator M.S. Chromosomal aberrations and response to γ-ray challenge in lymphocytes of workers exposed to 1,3-butadiene. Mutation Res. 334:1995;125-130.
55. Hallberg L.M., Bechtold W.E., Grady J., Legator M.S., Au W.W. Abnormal DNA repair activities in lymphocytes of workers exposed to 1,3-butadiene. Mutation Res. 383:1997;213-221.
56. Celotti L., Furland D., Ferraro P., Levis A.G. DNA repair and replication in lymphocytes from smokers exposed in vitro to UV-light. Mutagenesis. 4:1989;82-86.
57. Mayer J., Warburton D., Jeffrey A.M., Pero R., Walles S., Andrews L., Toor M., Latriano L., Wazneh L., Tang D., Tsai W.Y., Kuroda M., Pedera F. Biologic markers in ethylene oxide-exposed workers and controls. Mutation Res. 248:1991;163-176.
58. Knight R.D., Parsad R., Price F.M., Tarone R.E., Sanford K.K. X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int. J. Cancer. 54:1993;589-593.
59. Oliveri G., Bodycote J., Wolf S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science. 223:1984;594-597.
60. Itoh S., Shimada H. Micronucleus induction by chromium and selenium, and suppression by metallothionein inducer. Mutation Res. 367:1996;233-236.